Web Analytics

3 Latest Announced Rounds

  • $9,000,000
    Unknown

    6 Investors

    Software Development
    Jul 11th, 2025
  • $8,500,000
    Seed

    1 Investors

    Software Development
    Jul 11th, 2025
  • $250,000,000
    Unknown
    Financial Services
    Jul 11th, 2025
$1,602.71M Raised in 64 Funding Rounds in the past 7 Days - View All

Funding Round Profile

Ratio Therapeutics

start up
United States - Boston, MA
  • 02/12/2021
  • Unknown
  • $1,500,000

A discovery through early clinical phase pharmaceutical company, Ratio Therapeutics employs a suite of innovative technologies to develop best-in-class targeted radiotherapeutics for the treatment of cancer.

Ratio Therapeutics’ Trillium™ targeting scaffold combines pharmacokinetic modulation with best-in-class chelation technology to create proprietary small molecule targeting agents to attack a broad array of cancer targets. Our compounds accommodate imaging and therapeutic radioisotopes, ie "theranostics". The tunable nature of our platform combined with small-scale imaging trials in patients results in accelerated, de-risked compound selection.


Related People

Jack HoppinFounder

Jack Hoppin United States - Boston, Massachusetts,

NA